Balsamic liniment Wishnevsky (Liniment) Instructions for Use
ATC Code
D08AX (Other antiseptics and disinfectants)
Active Substances
Xeroform (Grouping name)
Tar (BP British Pharmacopoeia)
Clinical-Pharmacological Group
A drug with antimicrobial, anti-inflammatory, and tissue regeneration-improving action for external use
Pharmacotherapeutic Group
Antiseptics and disinfectants; other antiseptics and disinfectants
Pharmacological Action
A combined drug for external use.
Tar and Xeroform (Bismuth tribromophenolate and bismuth oxide complex) exert antimicrobial and local irritant action and accelerate regeneration processes.
Indications
- Infectious and inflammatory skin diseases, including: abscess, furuncle, lymphadenitis, lymphangitis, burns, frostbite, wounds, ulcers, bedsores.
ICD codes
| ICD-10 code | Indication |
| I83.2 | Varicose veins of lower extremities with ulcer and inflammation |
| I88.9 | Non-specific lymphadenitis, unspecified |
| I89.1 | Lymphangitis |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L08.8 | Other specified local infections of skin and subcutaneous tissue |
| L89 | Decubitus ulcer and pressure area |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| T14.1 | Open wound of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| T33 | Superficial frostbite |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| ICD-11 code | Indication |
| 1B70.Z | Bacterial cellulitis or lymphangitis caused by unspecified bacterium |
| 1B75.0 | Furuncle |
| 1B75.1 | Carbuncle |
| 1B75.2 | Furunculosis |
| 1B75.3 | Pyogenic skin abscess |
| 1B7Y | Other specified pyogenic bacterial infections of skin or subcutaneous tissue |
| 1C44 | Non-pyogenic bacterial infections of skin |
| BD74.Z | Chronic venous insufficiency of lower extremities, unspecified |
| BD90.Z | Lymphadenitis, unspecified |
| BD91 | Lymphangitis |
| EA40 | Tropical phagedenic ulcer |
| EA50.3 | Staphylococcal scarlet fever |
| EF60 | Ischemic ulceration of the skin |
| EH90.Z | Pressure ulcer of unspecified degree |
| EM0Z | Unspecified skin disorder |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| ND56.1 | Open wound of unspecified body region |
| NE11 | Burn of unspecified body region |
| NE40 | Superficial frostbite |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply externally only. Use a thin layer on the affected skin area.
Alternatively, apply a bandage: impregnate 5-6 layers of gauze with the liniment and place it on the affected area.
Follow the frequency of application and treatment duration as directed by a physician.
Adverse Reactions
Allergic reactions are possible. These may include localized skin rash, itching, redness, or swelling at the application site.
Discontinue use immediately and consult a physician if any signs of a hypersensitivity reaction occur.
Drug Interactions
No specific drug interactions with other topical or systemic medications have been formally established.
Avoid concurrent use with other topical preparations (ointments, creams, lotions) on the same skin area to prevent unpredictable effects or altered absorption.
Inform your physician about all medications you are using before initiating treatment.
Contraindications
- Hypersensitivity to Xeroform (bismuth tribromophenolate), tar, or any other component of the liniment.
Avoid application on large areas of damaged skin or severe burn surfaces without specific medical supervision.
Overdose
Systemic absorption after topical application is unlikely; overdose is not expected.
Excessive or prolonged application on large skin areas, especially with impaired skin barrier, may theoretically lead to bismuth absorption.
In case of suspected overdose, discontinue use and seek medical attention. Treatment is symptomatic.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Liniment 30 mg+30 mg/1 g: tubes 30 g and 35 g, jars 25 g, 40 g or 100 g
Marketing Authorization Holder
Altayvitamins, JSC (Russia)
Dosage Form
 |
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: tubes 30 g and 35 g, jars 25 g, 40 g or 100 g |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
25 g – jars (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
35 g – tubes (1) – cardboard packs.
40 g – jars (1) – cardboard packs.
100 g – jars (1) – cardboard packs.
Liniment 30 mg+30 mg/1 g: tube 40 g, jars 40 g or 100 g
Marketing Authorization Holder
Borisov Plant Of Medical Preparations, PJSC (Republic Of Belarus)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: tube 40 g, jars 40 g or 100 g |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
40 g – jars (1) – cardboard packs.
40 g – tubes (1) – cardboard packs.
100 g – jars (1) – cardboard packs.
Liniment 30 mg+30 mg/1 g: tubes 25 g, 30 g or 40 g
Marketing Authorization Holder
Vita Line, LLC (Russia)
Manufactured By
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: tubes 25 g, 30 g or 40 g |
Dosage Form, Packaging, and Composition
Liniment for external use from light yellow to brown with a greenish tint, with a characteristic odor.
| 1 g | |
| Tar | 30 mg |
| Xeroform | 30 mg |
Excipients: Aerosil (colloidal silicon dioxide) – 5 g, castor oil – 89 g.
25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
40 g – aluminum tubes (1) – cardboard packs.
Liniment 30 mg+30 mg/1 g: tube 30 g, jars 25 g, 40 g, 50 g or 100 g
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: tube 30 g, jars 25 g, 40 g, 50 g or 100 g |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
30 g – aluminum tubes (1) – cardboard packs.
25 g – orange glass jars (1) – cardboard packs.
40 g – orange glass jars (1) – cardboard packs.
50 g – orange glass jars (1) – cardboard packs.
100 g – orange glass jars (1) – cardboard packs.
25 g – orange glass jars (10) – cardboard boxes.
40 g – orange glass jars (10) – cardboard boxes.
50 g – orange glass jars (10) – cardboard boxes.
100 g – orange glass jars (10) – cardboard boxes.
Liniment: tube 30 g, jars 0.1 kg, 0.5 kg, 1 kg, 1.5 kg, 2 kg, 2.5 kg, 3 kg, 5 kg, 10 kg or 20 kg
Marketing Authorization Holder
Zelenaya Dubrava, CJSC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment: tube 30 g, jars 0.1 kg, 0.5 kg, 1 kg, 1.5 kg, 2 kg, 2.5 kg, 3 kg, 5 kg, 10 kg or 20 kg |
Dosage Form, Packaging, and Composition
Liniment from light yellow to brown with a specific odor.
| 100 g | |
| Tar | 3 g |
| Xeroform | 3 g |
Excipients: colloidal silicon dioxide (aerosil) – 5 g, castor oil – 89 g.
30 g – aluminum tubes (1) – cardboard packs.
0.1 kg – polymer jars.
0.5 kg – polymer jars.
1 kg – polymer jars.
1.5 kg – polymer jars.
2 kg – polymer jars.
2.5 kg – polymer jars.
3 kg – polymer jars.
5 kg – polymer jars.
10 kg – polymer jars.
20 kg – polymer jars.
Liniment 30 mg+30 mg/1 g: tubes or jars
Marketing Authorization Holder
Ivanovo Pharmaceutical Factory PJSC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: tubes or jars |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
Aluminum tubes (1) – cardboard packs.
Polyethylene jars (1) – cardboard packs.
Liniment 30 mg+30 mg/1 g: tube 30 g, jars 25 g or 40 g
Marketing Authorization Holder
Moscow Pharmaceutical Factory CJS (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: tube 30 g, jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
25 g – jars (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
40 g – jars (1) – cardboard packs.
Liniment 30 mg+30 mg/1 g: jar 25 g
Marketing Authorization Holder
Murom Instrument-Making Plant, FSUE (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: jar 25 g |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
30 g – aluminum tubes (1) – cardboard packs.
Liniment 30 mg+30 mg/1 g: tubes 30 g, 35 g, or 40 g, jars 25 g, 40 g, 50 g, 1000 g, or 2000 g
Marketing Authorization Holder
Nizhpharm JSC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: tubes 30 g, 35 g, or 40 g, jars 25 g, 40 g, 50 g, 1000 g, or 2000 g |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
25 g – jars (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
35 g – tubes (1) – cardboard packs.
40 g – jars (1) – cardboard packs.
40 g – tubes (1) – cardboard packs.
50 g – jars (1) – cardboard packs.
100 g – jars (1) – cardboard packs.
1000 g – jars (1) – wrapping paper.
2000 g – jars (1) – wrapping paper.
Liniment for external use
Marketing Authorization Holder
Obnovlenie Pfc, JSC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment for external use |
Dosage Form, Packaging, and Composition
Liniment for external use
| 100 g | |
| Birch tar | 3 g |
| Bismuth tribromophenolate and bismuth oxide complex (xeroform) | 3 g |
25 g – jars – cardboard packs – Over-the-counter
25 g – tubes – cardboard packs – Over-the-counter
30 g – jars – cardboard packs – Over-the-counter
30 g – tubes – cardboard packs – Over-the-counter
40 g – tubes – cardboard packs – Over-the-counter
Liniment 3 g+3 g: jars 5, 10, 15, 20, 25 or 30 g, tubes 30 g
Marketing Authorization Holder
Ozon, LLC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 3 g+3 g: jars 5, 10, 15, 20, 25 or 30 g, tubes 30 g |
Dosage Form, Packaging, and Composition
| Liniment | 100 g |
| Tar | 3 g |
| Xeroform | 3 g |
Excipients: castor oil 89 g, colloidal silicon dioxide 5 g.
5 g – dark glass jars (1) – cardboard packs.
10 g – dark glass jars (1) – cardboard packs.
15 g – dark glass jars (1) – cardboard packs.
20 g – dark glass jars (1) – cardboard packs.
25 g – dark glass jars (1) – cardboard packs.
30 g – dark glass jars (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
Liniment 30 mg+30 mg/1 g: 30 g tubes
Marketing Authorization Holder
St. Petersburg Research Institute of Vaccines and Sera of the FMBA, FSUE (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: 30 g tubes |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
Aluminum tubes (1) – cardboard packs.
Polyethylene jars (1) – cardboard packs.
Liniment 30 mg+30 mg/1 g: jar 25 g
Marketing Authorization Holder
Tver Pharmaceutical Factory, PJSC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: jar 25 g |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
25 g – jars.
Liniment 30 mg+30 mg/1 g: 25 g jars, 30 g or 50 g tubes
Marketing Authorization Holder
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: 25 g jars, 30 g or 50 g tubes |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
25 g – orange glass jars (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (1) – cardboard packs.
25 g – orange glass jars – group packaging.
30 g – aluminum tubes – group packaging.
50 g – aluminum tubes – group packaging.
Liniment for external use: 15 g, 20 g, 25 g, or 30 g jars, 25 g or 30 g tubes
Marketing Authorization Holder
Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment for external use: 15 g, 20 g, 25 g, or 30 g jars, 25 g or 30 g tubes |
Dosage Form, Packaging, and Composition
Liniment for external use from light yellow to greenish-brown in color, with a characteristic odor.
| 100 g | |
| Tar | 3 g |
| Xeroform | 3 g |
Excipients: colloidal silicon dioxide – 5 g, castor oil – 89 g.
15 g – jars (1) – cardboard packs.
20 g – jars (1) – cardboard packs.
25 g – jars (1) – cardboard packs.
30 g – jars (1) – cardboard packs.
25 g – tubes (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
Jars from 9 to 300 pcs. – cardboard boxes (for hospitals).
Tubes from 9 to 300 pcs. – cardboard boxes (for hospitals).
Liniment 30 mg+30 mg/1 g: tube 25 g
Marketing Authorization Holder
Pharmstandard-Fitopharm-NN LLC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: tube 25 g |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
25 g – tubes (1) – cardboard packs.
Liniment for external use 30 mg+30 mg/1 g: tubes 25 g, 30 g or 40 g
Marketing Authorization Holder
Formula-FR, LLC (Russia)
Manufactured By
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment for external use 30 mg+30 mg/1 g: tubes 25 g, 30 g or 40 g |
Dosage Form, Packaging, and Composition
Liniment for external use from light yellow to brown with a greenish tint, with a characteristic odor.
| 100 g | |
| Tar | 3 g |
| Xeroform | 3 g |
Excipients: Aerosil (colloidal silicon dioxide) – 5 g, castor oil – 89 g.
25 g – tubes (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
40 g – tubes (1) – cardboard packs.
Liniment 30 mg+30 mg/1 g: jar 25 g
Marketing Authorization Holder
Yaroslavl Pharmaceutical Factory, CJSC (Russia)
Dosage Form
|
Balsamic liniment Wishnevsky | Liniment 30 mg+30 mg/1 g: jar 25 g |
Dosage Form, Packaging, and Composition
| Liniment | 1 g |
| Tar | 30 mg |
| Xeroform | 30 mg |
25 g – jars (1) – cardboard packs.
![Balsamic liniment Wishnevsky [Liniment] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Balsamic liniment Wishnevsky [Liniment] 2")